A panel of federal judges is set to hear arguments regarding the abortion drug mifepristone. The focus of the hearing is on whether prescribing rules for this medication should be tightened. This comes as part of a consideration to restrict access to abortion pills via telehealth subscriptions.
Further details about the hearing and its potential implications are available from the source. The outcome of this hearing could impact how mifepristone is prescribed and accessed. For more information on this developing story, readers can refer to the original source for updates and additional context.
